Core Scientific, Inc.
CORZ
$22.79
-$0.16-0.70%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -160.25% | 155.14% | 67.79% | -16.39% | 173.51% |
| Total Depreciation and Amortization | -11.56% | -41.30% | -35.53% | -31.71% | -24.72% |
| Total Amortization of Deferred Charges | -3.29% | -5.45% | 5.98% | 251.18% | 162.42% |
| Total Other Non-Cash Items | 177.55% | -177.30% | -90.92% | 5.25% | -231.70% |
| Change in Net Operating Assets | 274.81% | 678.37% | 15,075.91% | 421.99% | 185.72% |
| Cash from Operations | 654.78% | 1,008.79% | 2,206.69% | 2,723.92% | -303.13% |
| Capital Expenditure | -363.47% | -855.58% | -684.28% | -3,768.55% | -163.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.91% | -27.50% | -15,239.39% | 100.00% | -6,526.32% |
| Cash from Investing | -334.36% | -849.11% | -714.21% | -3,656.53% | -178.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 75.47% | 95.23% | 99.79% | -106.56% | 74.13% |
| Issuance of Common Stock | -69.55% | 73.79% | -27.81% | -0.82% | -99.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 23,239.16% | -103.65% | -102.92% | -109.15% | -107.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 703.67% | -124.36% | -181.62% | -583.59% | -410.22% |